FidoCure Overview

  • Founded

  • 2014

Founded
  • Status

  • Private

  • Employees

  • 27

Employees
  • Latest Deal Type

  • Later Stage VC

  • Investors

  • 17

FidoCure General Information

Description

Provider of personalized medicine services intended to offer advanced cancer care beyond chemo and radiation for dogs. The company collects tissue samples for deoxyribonucleic acid (DNA) sequencing and creates a personalized deoxyribonucleic acid (DNA) report that helps identify genetic mutations that may affect treatment and then suggest targeted therapy for precisely attacking the cancer cells, enabling pet owners and veterinarians to eradicate canine cancer, thereby improving the quality of life for clients' canine friends.

Contact Information

Website
www.fidocure.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Clinics/Outpatient Services
Primary Office
  • 530 Lytton Avenue
  • 2nd Floor
  • Palo Alto, CA 94301
  • United States
+1 (215) 000-0000

FidoCure Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

FidoCure Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 01-Mar-2022 000.00 Completed Generating Revenue
7. Later Stage VC (Series A) 31-Mar-2021 000.00 000.00 000.00 Completed Generating Revenue
6. Seed Round 23-Jan-2019 000 00.000 000.00 Completed Generating Revenue
5. Secondary Transaction - Private 17-May-2018 00.000 Completed Generating Revenue
4. Debt - General 00.000 Completed Generating Revenue
3. Accelerator/Incubator 20-Mar-2018 00000 00.000 00.000 Completed Generating Revenue
2. Accelerator/Incubator 16-Jun-2017 $50K $1.25M Completed Generating Revenue
1. Seed Round 01-Mar-2017 $1.25M $1.25M Completed Generating Revenue
To view FidoCure’s complete valuation and funding history, request access »

FidoCure Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.00
Seed 000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
To view FidoCure’s complete cap table history, request access »

FidoCure Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of personalized medicine services intended to offer advanced cancer care beyond chemo and radiation for dogs. T
Clinics/Outpatient Services
Palo Alto, CA
27 As of 2023
000.00
0000000000 0 000.00

000000

t, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et do
000000000000000000 0
Bannockburn, IL
00 As of 0000
000
000000000 000

000000

esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat
0000 000000000
Barcelona, Spain
00 As of 0000
000.00
00.00 0000-00-00
0000000000 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

FidoCure Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
PetCure Oncology Venture Capital-Backed Bannockburn, IL 00 000 000000000 000
0000000 000000 Venture Capital-Backed Barcelona, Spain 00 000.00 0000000000 0 000.00
00000 Venture Capital-Backed Fort Collins, CO 0 00.000 0000000000 0 00.000
00000 Venture Capital-Backed Martinsried, Germany 00 00.000 000000000000 00.000
To view FidoCure’s complete competitors history, request access »

FidoCure Patents

  • 4

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 000

    Granted

  • 1

    Pending

  • 000

    Expiring in next 12 mo

FidoCure Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220354951-A1 Treatment of canine cancers Pending 02-Aug-2019 000000000
AU-2020326612-A1 Treatment of canine cancers Pending 02-Aug-2019 000000000
CA-3149796-A1 Treatment of canine cancers Pending 02-Aug-2019 000000000
EP-4007585-A1 Treatment of canine cancers Pending 02-Aug-2019 A61K41/00

FidoCure Executive Team (12)

Name Title Board Seat Contact Info
Christina Lopes Ph.D Co-Founder, Chief Executive Officer & Board Member
Gerald Post Ph.D Chief Medical Officer & Chief Veterinary Officer
Chase Schwalbach Chief Product Officer
Benjamin Lewis Co-Founder & Board Member
Ravi Tolwani Ph.D Advisor
You’re viewing 5 of 12 executive team members. Get the full list »

FidoCure Board Members (3)

Name Representing Role Since
Benjamin Lewis FidoCure Co-Founder & Board Member 000 0000
Christina Lopes Ph.D FidoCure Co-Founder, Chief Executive Officer & Board Member 000 0000
You’re viewing 2 of 3 board members. Get the full list »

FidoCure Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

FidoCure Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Bossanova Investimentos Venture Capital Minority 000 0000 000000 0
Global Brain Venture Capital Minority 000 0000 000000 0
Borealis Ventures Venture Capital Minority 000 0000 000000 0
Civilization Ventures Venture Capital Minority 000 0000 000000 0
For Good Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 17 investors. Get the full list »

Ready to get started?

Request a free trial